0001140361-13-012276.txt : 20130313 0001140361-13-012276.hdr.sgml : 20130313 20130313160215 ACCESSION NUMBER: 0001140361-13-012276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130311 FILED AS OF DATE: 20130313 DATE AS OF CHANGE: 20130313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hartman Thomas E CENTRAL INDEX KEY: 0001466989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 13687490 MAIL ADDRESS: STREET 1: HANGER ORTHOPEDIC GROUP, INC. STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2013-03-11 0 0000722723 HANGER, INC. HGR 0001466989 Hartman Thomas E 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 VP and General Counsel Common Stock 2013-03-11 4 A 0 2050 0 A 14800 D Common Stock 2013-03-12 4 S 0 600 29.5725 D 14200 D The restricted stock being reported does not include the contingent right of the reporting person to receive up to 2,050 additional performance shares under the issuer's 2010 Omnibus Incentive Plan based on the achievement of certain performance targets for the fiscal year 2013. The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. These shares were sold at a range of sale prices from $29.45 to $29.83. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Consists of (i) unvested restricted shares totaling 2,050 shares of stock from an initial grant of 2,050 shares of restricted stock made on March 11, 2013; (ii) unvested restricted shares and fully vested shares totaling 4,200 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012; (iii) unvested restricted shares totaling 3,450 shares from an initial grant of 4,600 shares of restricted stock made on March 25, 2011; (iv) unvested restricted shares totaling 3,250 shares from an initial grant of 6,500 shares of restricted stock made on March 30, 2010, and [continued in next footnote] (v) unvested restricted shares totaling 1,250 shares from an initial grant of 5,000 shares of restricted stock that vest to the extent of one-quarter on June 25, 2010 and cumulatively vest to the extent of one-quarter each year thereafter, subject to certain provisions under the Plan, and which shall become fully vested upon a termination of employment not involving termination for cause or voluntary termination. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Hartman 2013-03-13